Session Type
Date Time

HIV prevention approaches can only work if they meet the needs of, and are able to reach, the people who need them most. Today's plenary explores the population-specific considerations in prevention product development and delivery that can bridge the gap between success in the lab and real impact for individuals and communities.

PL03.01 Viral networks and their implications for prevention policy
Christophe FRASER, University of Oxford, Big Data Institute, United Kingdom

PL03.02 Beginning with the end in mind: What we (think we) know about prevention user preferences
Ram PRASAD, FinalMile Consulting, India
PL03.03 We're all in this together: Leaving no one behind in biomedical prevention research
Adeeba KAMARULZAMAN, University of Malaya, Malaysia

PL03.04 The Omololu Falobi Award